Previous 10 | Next 10 |
Summary IHE tracks the Dow Jones U.S. Select Pharmaceuticals Total Return Index, which invests solely in U.S. pharmaceutical companies. The fund is top-heavy, investing around 40% in just two companies: Johnson & Johnson and Eli Lilly. IHE could capitalize on the pharmaceutical ...
Summary When I think about the lessons learned from 2022, I think the biggest lesson is valuations matter. I do think this is the most predicted recession that I've ever seen, certainly, in my career. Investors of all stripes, whether you're an asset allocator or a stock picker, I t...
Summary Even in its battered condition, the therapeutics sub-sector still accounts for 9.1% of the Russell 2000 Growth index. M&A activity continues to heat up as big players—currently flush with cash—look to drive growth by filling their development pipelines. In ...
Summary Last year’s market volatility was driven primarily by uncertainty over inflation and interest rates. In last year’s downturn, technology stocks were at the epicenter of market volatility. After years of steady gains, investors now acknowledge that technology stocks...
Summary Healthcare stocks have remained in vogue through volatile markets, driven by increased interest in the sector during COVID-19. During a painful year for equity investors in 2022, healthcare stocks offered a pocket of relative stability. Global healthcare stocks ended the yea...
Summary How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector. How staff shortages in the health care sector may also impact investors. Health care managed to outperform the S&P 500 last yea...
Summary The storm that descended upon capital markets in 2022 is expected to continue into the New Year. The probability of a recession in 2023 remains elevated. The Fed remains steadfast with tight monetary policy and corporate earnings are historically elevated. Be not afraid....
Summary Merck & Co., Inc. substantially outperformed in 2022. Merck achieved a series of positive trial outcomes and approvals. Global revenue growth has been solid. The Wall Street consensus rating is a buy, but MRK's current share price is close to the 12-month price targe...
Summary The top two mega themes in terms of global net inflows in 2022 were Climate Change-related themes and Big Data. The largest net outflows came from tech-heavy themes, led by Robotics & Automation. 2023 may bring a return to more normal markets driven by economics rather t...
Summary LLY is one of the best performing pharmaceutical stocks in 2022 and has reached a $340 billion market cap. It appears to be extremely overvalued regardless of the valuation methodology used and is worth more than peers like PFE and MRK that have larger businesses and operations....
News, Short Squeeze, Breakout and More Instantly...
iShares U.S. Pharmaceutical Company Name:
IHE Stock Symbol:
NYSE Market:
2024-07-12 08:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-22 11:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-31 20:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...